Gabriella Maria Pia Ciotti

Author

Università Cattolica del Sacro Cuore ORCID

Also Known As

Ciotti, Gabriella Maria Pia, G Ciotti, G.M.P. Ciotti, Gabriella Maria Pia Ciotti, Gabriella Pia Ciotti

Publications

445

Citations

H-Index

Concepts

All Affiliations

Università Cattolica del Sacro Cuore Agostino Gemelli University Polyclinic Istituti di Ricovero e Cura a Carattere Scientifico University of Illinois Chicago University of Rome Tor Vergata

About

Gabriella Maria Pia Ciotti is an author at Università Cattolica del Sacro Cuore specializing in neuroinflammation, tumor microenvironment, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	230
2	Cell Biology	1	1	230
3	Immunology	1	1	230
4	Neurology	1	1	230
5	Inflammation	1	1	230

Gabriella Maria Pia Ciotti

Publications

416

Citations

H-Index

Page 1

	Year	Citations
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma Lucia Lisi, Gabriella Maria Pia Ciotti, David J. Braun, Neuroscience Letters InflammationNeuro-oncologyMicroglial PolarizationGliomaM2 Markers	2017	230
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections Gennaro De Pascale, Lucia Lisi, Gabriella Maria Pia Ciotti, Annals of Intensive Care	2020	62
PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation Marta Chiavari, Gabriella Maria Pia Ciotti, Francesco Canonico, International Journal of Molecular Sciences	2020	43
Pro-Inflammatory Activation of a New Immortalized Human Microglia Cell Line Marta Chiavari, Gabriella Maria Pia Ciotti, Pierluigi Navarra, Brain Sciences	2019	26
Phospho-mTOR expression in human glioblastoma microglia-macrophage cells Lucia Lisi, Gabriella Maria Pia Ciotti, Marta Chiavari, Neurochemistry International	2019	25
Vascular endothelial growth factor receptor 1 in glioblastoma‑associated microglia/macrophages Lucia Lisi, Gabriella Maria Pia Ciotti, Marta Chiavari, Oncology Reports	2020	18
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features Gennaro De Pascale, Gabriele Pintaudi, Lucia Lisi, Antibiotics	2023	12

Page 1